Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type

James D. Weisfeld-Adams, H. Allison Bender, Anna Miley-Åkerstedt, Tamiesha Frempong, Nina L. Schrager, Keyur Patel, Thomas P. Naidich, Victoria Stein, Jessica Spat, Stephanie Towns, Melissa P. Wasserstein, Inga Peter, Yitzchak Frank, George A. Diaz

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Abnormal neurodevelopment has been widely reported in combined methylmalonic aciduria (MMA) and homocystinuria, cblC type (cblC disease), but neurodevelopmental phenotypes in cblC have not previously been systematically studied. We sought to further characterize developmental neurology in children with molecularly-confirmed cblC. Thirteen children at our center with cblC, born since implementation of expanded newborn screening in New York State, undertook standard-of-care evaluations with a pediatric neurologist and pediatric ophthalmologist. At most recent follow-up (mean age 50. months, range 9-84. months), of twelve children with early-onset cblC, three (25%) had a history of clinical seizures and two (17%) meet criteria for microcephaly. A majority of children had hypotonia and nystagmus. Twelve out of thirteen (92%) underwent neurodevelopmental evaluation (mean age 41. months; range 9-76. months), each child tested with standardized parental interviews and, where possible, age- and disability-appropriate neuropsychological batteries. All patients showed evidence of developmental delay with the exception of one patient with a genotype predictive of attenuated disease and near-normal biochemical parameters. Neurodevelopmental deficits were noted most prominently in motor skills, with relative preservation of socialization and communication skills. Nine children with early-onset cblC underwent magnetic resonance imaging and spectroscopy (MRI/MRS) at mean age of 47. months (range 6-81. months); common abnormalities included callosal thinning, craniocaudally short pons, and increased T2 FLAIR signal in periventricular and periatrial white matter. Our study further characterizes variable neurodevelopmental phenotypes in treated cblC, and provides insights into the etiopathogenesis of disordered neurodevelopment frequently encountered in cblC. Plasma homocysteine and MMA, routinely measured at clinical follow-up, may be poor predictors for neurodevelopmental outcomes. Additional data from large, prospective, multi-center natural history studies are required to more accurately define the role of these metabolites and others, as well as that of other genetic and environmental factors in the etiopathogenesis of the neurologic components of this disorder.

Original languageEnglish (US)
Pages (from-to)241-247
Number of pages7
JournalMolecular Genetics and Metabolism
Volume110
Issue number3
DOIs
StatePublished - Nov 2013
Externally publishedYes

Fingerprint

Pediatrics
Vitamin B 12
Nervous System
Magnetic resonance spectroscopy
Phenotype
Eye movements
Neurology
Homocysteine
Metabolites
Screening
Plasmas
Imaging techniques
Communication
Microcephaly
Muscle Hypotonia
Motor Skills
Socialization
Pons
Corpus Callosum
Standard of Care

Keywords

  • Cobalamin C
  • Homocystinuria
  • Methylmalonic acidemia
  • MMACHC
  • Neurodevelopment
  • Newborn screening

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. / Weisfeld-Adams, James D.; Bender, H. Allison; Miley-Åkerstedt, Anna; Frempong, Tamiesha; Schrager, Nina L.; Patel, Keyur; Naidich, Thomas P.; Stein, Victoria; Spat, Jessica; Towns, Stephanie; Wasserstein, Melissa P.; Peter, Inga; Frank, Yitzchak; Diaz, George A.

In: Molecular Genetics and Metabolism, Vol. 110, No. 3, 11.2013, p. 241-247.

Research output: Contribution to journalArticle

Weisfeld-Adams, JD, Bender, HA, Miley-Åkerstedt, A, Frempong, T, Schrager, NL, Patel, K, Naidich, TP, Stein, V, Spat, J, Towns, S, Wasserstein, MP, Peter, I, Frank, Y & Diaz, GA 2013, 'Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type', Molecular Genetics and Metabolism, vol. 110, no. 3, pp. 241-247. https://doi.org/10.1016/j.ymgme.2013.07.018
Weisfeld-Adams, James D. ; Bender, H. Allison ; Miley-Åkerstedt, Anna ; Frempong, Tamiesha ; Schrager, Nina L. ; Patel, Keyur ; Naidich, Thomas P. ; Stein, Victoria ; Spat, Jessica ; Towns, Stephanie ; Wasserstein, Melissa P. ; Peter, Inga ; Frank, Yitzchak ; Diaz, George A. / Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. In: Molecular Genetics and Metabolism. 2013 ; Vol. 110, No. 3. pp. 241-247.
@article{dc3aa9d01737461086e95f0f2b9c066c,
title = "Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type",
abstract = "Abnormal neurodevelopment has been widely reported in combined methylmalonic aciduria (MMA) and homocystinuria, cblC type (cblC disease), but neurodevelopmental phenotypes in cblC have not previously been systematically studied. We sought to further characterize developmental neurology in children with molecularly-confirmed cblC. Thirteen children at our center with cblC, born since implementation of expanded newborn screening in New York State, undertook standard-of-care evaluations with a pediatric neurologist and pediatric ophthalmologist. At most recent follow-up (mean age 50. months, range 9-84. months), of twelve children with early-onset cblC, three (25{\%}) had a history of clinical seizures and two (17{\%}) meet criteria for microcephaly. A majority of children had hypotonia and nystagmus. Twelve out of thirteen (92{\%}) underwent neurodevelopmental evaluation (mean age 41. months; range 9-76. months), each child tested with standardized parental interviews and, where possible, age- and disability-appropriate neuropsychological batteries. All patients showed evidence of developmental delay with the exception of one patient with a genotype predictive of attenuated disease and near-normal biochemical parameters. Neurodevelopmental deficits were noted most prominently in motor skills, with relative preservation of socialization and communication skills. Nine children with early-onset cblC underwent magnetic resonance imaging and spectroscopy (MRI/MRS) at mean age of 47. months (range 6-81. months); common abnormalities included callosal thinning, craniocaudally short pons, and increased T2 FLAIR signal in periventricular and periatrial white matter. Our study further characterizes variable neurodevelopmental phenotypes in treated cblC, and provides insights into the etiopathogenesis of disordered neurodevelopment frequently encountered in cblC. Plasma homocysteine and MMA, routinely measured at clinical follow-up, may be poor predictors for neurodevelopmental outcomes. Additional data from large, prospective, multi-center natural history studies are required to more accurately define the role of these metabolites and others, as well as that of other genetic and environmental factors in the etiopathogenesis of the neurologic components of this disorder.",
keywords = "Cobalamin C, Homocystinuria, Methylmalonic acidemia, MMACHC, Neurodevelopment, Newborn screening",
author = "Weisfeld-Adams, {James D.} and Bender, {H. Allison} and Anna Miley-{\AA}kerstedt and Tamiesha Frempong and Schrager, {Nina L.} and Keyur Patel and Naidich, {Thomas P.} and Victoria Stein and Jessica Spat and Stephanie Towns and Wasserstein, {Melissa P.} and Inga Peter and Yitzchak Frank and Diaz, {George A.}",
year = "2013",
month = "11",
doi = "10.1016/j.ymgme.2013.07.018",
language = "English (US)",
volume = "110",
pages = "241--247",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type

AU - Weisfeld-Adams, James D.

AU - Bender, H. Allison

AU - Miley-Åkerstedt, Anna

AU - Frempong, Tamiesha

AU - Schrager, Nina L.

AU - Patel, Keyur

AU - Naidich, Thomas P.

AU - Stein, Victoria

AU - Spat, Jessica

AU - Towns, Stephanie

AU - Wasserstein, Melissa P.

AU - Peter, Inga

AU - Frank, Yitzchak

AU - Diaz, George A.

PY - 2013/11

Y1 - 2013/11

N2 - Abnormal neurodevelopment has been widely reported in combined methylmalonic aciduria (MMA) and homocystinuria, cblC type (cblC disease), but neurodevelopmental phenotypes in cblC have not previously been systematically studied. We sought to further characterize developmental neurology in children with molecularly-confirmed cblC. Thirteen children at our center with cblC, born since implementation of expanded newborn screening in New York State, undertook standard-of-care evaluations with a pediatric neurologist and pediatric ophthalmologist. At most recent follow-up (mean age 50. months, range 9-84. months), of twelve children with early-onset cblC, three (25%) had a history of clinical seizures and two (17%) meet criteria for microcephaly. A majority of children had hypotonia and nystagmus. Twelve out of thirteen (92%) underwent neurodevelopmental evaluation (mean age 41. months; range 9-76. months), each child tested with standardized parental interviews and, where possible, age- and disability-appropriate neuropsychological batteries. All patients showed evidence of developmental delay with the exception of one patient with a genotype predictive of attenuated disease and near-normal biochemical parameters. Neurodevelopmental deficits were noted most prominently in motor skills, with relative preservation of socialization and communication skills. Nine children with early-onset cblC underwent magnetic resonance imaging and spectroscopy (MRI/MRS) at mean age of 47. months (range 6-81. months); common abnormalities included callosal thinning, craniocaudally short pons, and increased T2 FLAIR signal in periventricular and periatrial white matter. Our study further characterizes variable neurodevelopmental phenotypes in treated cblC, and provides insights into the etiopathogenesis of disordered neurodevelopment frequently encountered in cblC. Plasma homocysteine and MMA, routinely measured at clinical follow-up, may be poor predictors for neurodevelopmental outcomes. Additional data from large, prospective, multi-center natural history studies are required to more accurately define the role of these metabolites and others, as well as that of other genetic and environmental factors in the etiopathogenesis of the neurologic components of this disorder.

AB - Abnormal neurodevelopment has been widely reported in combined methylmalonic aciduria (MMA) and homocystinuria, cblC type (cblC disease), but neurodevelopmental phenotypes in cblC have not previously been systematically studied. We sought to further characterize developmental neurology in children with molecularly-confirmed cblC. Thirteen children at our center with cblC, born since implementation of expanded newborn screening in New York State, undertook standard-of-care evaluations with a pediatric neurologist and pediatric ophthalmologist. At most recent follow-up (mean age 50. months, range 9-84. months), of twelve children with early-onset cblC, three (25%) had a history of clinical seizures and two (17%) meet criteria for microcephaly. A majority of children had hypotonia and nystagmus. Twelve out of thirteen (92%) underwent neurodevelopmental evaluation (mean age 41. months; range 9-76. months), each child tested with standardized parental interviews and, where possible, age- and disability-appropriate neuropsychological batteries. All patients showed evidence of developmental delay with the exception of one patient with a genotype predictive of attenuated disease and near-normal biochemical parameters. Neurodevelopmental deficits were noted most prominently in motor skills, with relative preservation of socialization and communication skills. Nine children with early-onset cblC underwent magnetic resonance imaging and spectroscopy (MRI/MRS) at mean age of 47. months (range 6-81. months); common abnormalities included callosal thinning, craniocaudally short pons, and increased T2 FLAIR signal in periventricular and periatrial white matter. Our study further characterizes variable neurodevelopmental phenotypes in treated cblC, and provides insights into the etiopathogenesis of disordered neurodevelopment frequently encountered in cblC. Plasma homocysteine and MMA, routinely measured at clinical follow-up, may be poor predictors for neurodevelopmental outcomes. Additional data from large, prospective, multi-center natural history studies are required to more accurately define the role of these metabolites and others, as well as that of other genetic and environmental factors in the etiopathogenesis of the neurologic components of this disorder.

KW - Cobalamin C

KW - Homocystinuria

KW - Methylmalonic acidemia

KW - MMACHC

KW - Neurodevelopment

KW - Newborn screening

UR - http://www.scopus.com/inward/record.url?scp=84885429889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885429889&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2013.07.018

DO - 10.1016/j.ymgme.2013.07.018

M3 - Article

C2 - 23954310

AN - SCOPUS:84885429889

VL - 110

SP - 241

EP - 247

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 3

ER -